Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/1998
08/27/1998WO1998036750A1 Anti-microbial product
08/27/1998WO1998036749A1 Tetralone derivatives as antiarrhythmic agents
08/27/1998WO1998036748A1 Methods and compositions for the protection of mitochondria
08/27/1998WO1998036747A1 Pharmaceutical composition
08/27/1998WO1998036746A1 Use of substituted (5,6)-dihydronaphthalenyl compounds having retinoid-like activity to prevent or reduce ischemic injury
08/27/1998WO1998036745A2 Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis
08/27/1998WO1998036744A1 Use of milnacipran and its derivatives for preparing a medicine for treating certain psychiatric diseases
08/27/1998WO1998036743A1 Neuroprotective poly-guanidino compounds which block presynaptic n and p/q calcium channels
08/27/1998WO1998036742A1 Methods and compositions for preventing and treating chronological aging in human skin
08/27/1998WO1998036741A2 Use of 2-desoxyglucose for suppressing viral transcription
08/27/1998WO1998036736A1 Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation
08/27/1998WO1998036735A1 Aqueous pharmaceutical composition comprising an active ingredient which is highly insoluble in water
08/27/1998WO1998036733A2 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
08/27/1998WO1998036732A2 Combination preparation for orally administered antibiotics
08/27/1998WO1998036731A1 Use of azoles
08/27/1998WO1998036730A2 Compositions for treating acne rosacea
08/27/1998WO1998036728A2 Sustained analgesia achieved with buprenorphine
08/27/1998WO1998029103A3 Use of calcium dobesilate for the manufacture of a medicament for the treatment of embryonic retardation
08/27/1998WO1998027930A3 New use of aminopiperazine derivatives
08/27/1998WO1998026780A3 Flat medicament preparation for the application and release of buprenorphine or a pharmacologically comparable substance in the buccal cavity, and method of producing the same
08/27/1998WO1998025640A3 Novel methods for testing inhibitors of paired helical filaments and uses for treatment of alzheimer's disease
08/27/1998WO1998024802A3 Compound
08/27/1998WO1998024782A3 Substituted pyrimidine compounds and their use
08/27/1998WO1998024396A3 Methods of treating mental diseases, inflammation and pain
08/27/1998WO1998023260A3 Non-ionic surfactant vesicles as a delivery agent for nucleic acid
08/27/1998WO1998022441A3 N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions, and methods for inhibiting beta-amyloid peptide and/or its synthesis
08/27/1998WO1998019997A3 Dihydropyrones with improved antiviral activity
08/27/1998WO1998015295A3 Radiopharmaceuticals for imaging infection and inflammation
08/27/1998WO1998013499A3 Packaging cell lines for use in facilitating the development of high-capacity adenoviral vectors
08/27/1998WO1998013031A3 Medicinal aerosol formulations comprising budesonide
08/27/1998WO1998010786A3 Pharmaceutical composition for the treatment of syndrome x of reaven
08/27/1998WO1998009623A3 Use of cholinergic drugs
08/27/1998WO1998007844A3 Screening assay for the identification of agents which alter expression of pth-rp
08/27/1998WO1998006437A3 Compositions and methods for polynucleotide delivery
08/27/1998WO1998004236A3 Antiperspirant or deodorant composition with silicone latex
08/27/1998DE19740785A1 Arylsulfonamide und Analoga Aryl sulfonamides and analogues
08/27/1998DE19716905C1 Aqueous L-selegilin solution for treating Parkinson's disease
08/27/1998DE19711565A1 Zubereitungen für die Behandlung von Rosacea Preparations for the treatment of rosacea
08/27/1998DE19708461A1 Use of aminergic substances to prepare medicaments
08/27/1998DE19707628A1 Oxazolidinone Oxazolidinones
08/27/1998DE19707596A1 Improvement of vascular blood flow
08/27/1998DE19706978A1 Kombinationspräparat für oral applizierbare Antibiotika Combined preparation for orally administered antibiotics
08/27/1998DE19706357A1 Use of mixtures of plant phospholipid(s) with oils rich in docosa-hexanoic acid and/or eicosa-pentanoic acid
08/27/1998DE19705538C1 Verfahren zur Trennung von Wirkstoffen in festen pharmazeutischen Zubereitungen A process for the separation of active ingredients in solid pharmaceutical preparations
08/27/1998CA2554085A1 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
08/27/1998CA2282467A1 Preparations for the treatment of metabolic syndrome containing human growth hormone in combination with a cortisol synthesis inhibitor
08/27/1998CA2282086A1 Use of 9, 10-secocholesta-5,7,10(19)-triene-1,3-diol, or alfacacidol
08/27/1998CA2281948A1 Inhibition of major groove dna binding proteins by modified polyamides
08/27/1998CA2281947A1 Improved polyamides for binding in the minor groove of double stranded dna
08/27/1998CA2281930A1 Design, synthesis and use of specific polyamide dna-binding ligands
08/27/1998CA2281919A1 Gel delivery vehicles for anticellular proliferative agents
08/27/1998CA2281899A1 Modified retinoblastoma tumor suppressor proteins
08/27/1998CA2281800A1 7a-heterocycle-substituted hexahydro-1h-pyrrolizine compounds useful in controlling chemical synaptic transmission
08/27/1998CA2281799A1 Methods and compositions for the protection of mitochondria
08/27/1998CA2281564A1 Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds
08/27/1998CA2281524A1 Anti-microbial product
08/27/1998CA2281509A1 Use of substituted (5,6)-dihydronaphthalenyl compounds having retinoid-like activity to prevent or reduce ischemic injury
08/27/1998CA2280008A1 Compounds for inhibition of gastric acid secretion
08/27/1998CA2276339A1 Transdermal pressure sensitive adhesive drug delivery system and pressure sensitive adhesive used therein
08/27/1998CA2272478A1 Sulfonylurea-glitazone synergistic combinations for diabetes
08/27/1998CA2251646A1 Methods for preventing and treating pestivirus infection and associated diseases
08/27/1998CA2251645A1 Eukaryotic cells expressing at their surface at least an hla-g isoform and their applications
08/27/1998CA2198645A1 Use of dillapiol and its analogues and derivatives to affect multidrug resistant cells
08/26/1998EP0860506A1 Human protein kinase hYAKI (HOACF 72)
08/26/1998EP0860445A1 New nucleotide sequences for the cell cycle regulated expression of structural genes
08/26/1998EP0860440A1 Sulfonamido substituted chromane derivatives with potassium channel blocking activity
08/26/1998EP0860428A2 Sulphonamide derivatives
08/26/1998EP0860422A1 Derivatives of benzylidene cyclohexanone, benzylidene cyclopentanone, and benzylidene acetone and their synthesis.
08/26/1998EP0860170A1 Isotopic urea tablets
08/26/1998EP0860168A2 Use of central cannbinoid receptor CB1 agonists
08/26/1998EP0859860A1 Diagnosis of susceptibility to cancer and treatment thereof
08/26/1998EP0859853A1 Method for transferring genes to the heart using aav vectors
08/26/1998EP0859847A1 Composition and method of imparting resistivity to hiv superinfection to cells
08/26/1998EP0859844A1 Interleuken-3 (il-3) receptor agonists
08/26/1998EP0859842A1 SHORT FORMS OF CHEMOKINE $g(b)-8
08/26/1998EP0859840A1 Biologically active eph family ligands
08/26/1998EP0859838A1 Novel procollagens
08/26/1998EP0859837A2 Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor
08/26/1998EP0859787A1 G-protein coupled receptor hnfds78
08/26/1998EP0859786A1 Peptide derivatives of dolastatin 15 and their use
08/26/1998EP0859784A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation
08/26/1998EP0859783A1 Process for isolating immunoglobulins in whey
08/26/1998EP0859780A1 Isolation of clavulanic acid from fermentation broth by ultrafiltration
08/26/1998EP0859779A1 Interleukin converting enzyme and apoptosis
08/26/1998EP0859778A2 Chemical compounds
08/26/1998EP0859777A1 8-azabicyclo 3.2.1]oct-2-ene derivatives, their preparation and use
08/26/1998EP0859776A1 Compounds derived from oxazolidin-2-one and preparation and therapeutical use thereof
08/26/1998EP0859775A1 Compounds derived from 3-(benzofuran-5-yl)oxazolidin-2-one, preparation method therefor and therapeutical use thereof
08/26/1998EP0859773A1 Phenol derivatives with pharmaceutical activity
08/26/1998EP0859771A1 Substituted pyridyl pyrroles, compositions containing such compounds and methods of use
08/26/1998EP0859769A1 Esters of non-steroidal anti-inflammatory carboxylic acids
08/26/1998EP0859766A1 Chiral methyl phenyl oxazolidinones
08/26/1998EP0859763A1 Dihydrophthalazine antagonists of excitatory amino acid receptors
08/26/1998EP0859762A1 Cytokine production inhibitors, formulations thereof and their use in medicine, and methods for their identification
08/26/1998EP0859761A1 4-azasteroids for treatment of hyperandrogenic conditions
08/26/1998EP0859760A1 Tricyclic pyrrolidine derivatives as calcium channel antagonists
08/26/1998EP0859757A1 Derivates of n,n-dimethyl-2-(arylthio)benzylamine, their salts, methods of preparation and their use in pharmaceutical medicaments
08/26/1998EP0859751A1 Semi-fluorinated alkanes and their use
08/26/1998EP0859642A2 Method of detecting cyclooxygenase-2
08/26/1998EP0859639A1 Methods for treating cancers and restenosis with p21
1 ... 6615 6616 6617 6618 6619 6620 6621 6622 6623 6624 6625 6626 6627 6628 6629 6630 6631 6632 6633 6634 6635 ... 7860